Galecto Inc (GLTO)

Currency in USD
27.830
-1.080(-3.74%)
Real-time Data·
GLTO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
26.42530.090
52 wk Range
2.01038.325
Key Statistics
Prev. Close
28.91
Open
28.75
Day's Range
26.425-30.09
52 wk Range
2.01-38.325
Volume
174.93K
Average Volume (3m)
177.11K
1-Year Change
585.468%
Book Value / Share
5.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GLTO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
46.750
Upside
+67.98%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

Galecto Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

Compare GLTO to Peers and Sector

Metrics to compare
GLTO
Peers
Sector
Relationship
P/E Ratio
−106.1x−3.5x−0.5x
PEG Ratio
−2.910.000.00
Price/Book
252.2x3.1x2.6x
Price / LTM Sales
-3.4x3.2x
Upside (Analyst Target)
55.7%232.3%51.2%
Fair Value Upside
Unlock8.3%7.3%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 46.750
(+67.98% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Guggenheim
Buy40.00+45.51%36.00Maintain17/02/2026
UBS
Buy45.00+63.70%-New Coverage17/02/2026
LifeSci Capital
Buy40.00+45.51%-New Coverage02/02/2026
Leerink Partners
Buy46.00+67.33%-New Coverage07/01/2026
Guggenheim
Buy36.00+30.96%32.00Maintain08/12/2025

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-2.36 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

0.5201
ENSC
-4.94%
7.1650
EDSA
+9.89%
0.653
SOPA
+2.05%
0.3979
ASNS
+24.00%

FAQ

What Is the Galecto (GLTO) Share Price Today?

The Galecto stock price today is 27.830 USD.

What Stock Exchange Does Galecto (GLTO) Trade On?

Galecto is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Galecto?

The stock symbol (also called a 'ticker') for Galecto is "GLTO."

What Is the Current Galecto Market Cap?

As of today, Galecto market cap is 1.660B USD.

What Is Galecto's (GLTO) Earnings Per Share (TTM)?

The Galecto EPS is currently -11.990 (Trailing Twelve Months).

Is GLTO a Buy or Sell From a Technical Analyst Perspective?

Based on today's Galecto moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Galecto Stock Split?

Galecto has split 1 times. (See the GLTO stock split history page for full effective split date and price information.)

How Many Employees Does Galecto Have?

Galecto has 5 employees.

What is the current trading status of Galecto (GLTO)?

As of 09/03/2026, Galecto (GLTO) is trading at a price of 27.830 USD, with a previous close of 28.910 USD. The stock has fluctuated within a day range of 26.425 USD to 30.090 USD, while its 52-week range spans from 2.010 USD to 38.325 USD.

What Is Galecto (GLTO) Price Target According to Analysts?

The average 12-month price target for Galecto is 46.750 USD, with a high estimate of 57 USD and a low estimate of 40 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +67.98% Upside potential.

What Is the GLTO Premarket Price?

GLTO's last pre-market stock price is 28.900 USD. The pre-market share volume is 320.000, and the stock has decreased by -0.010, or -0.030%.

What Is the GLTO After Hours Price?

GLTO's last after hours stock price is 26.340 USD, the stock has decreased by -2.570, or -8.890%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.